BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Nordic Nanovector: Updated Results From Phase I/II Trial of Betalutin in Non-Hodgkin Lymphoma to be Presented at ASH in December

  The dataset includes 55 evaluable patients. Data from patients receiving the two most promising dosing regimens in the Phase II expansion cohorts

  November 1, 2017

   · 

  6 min read
• 

  FDA

  Intellijoint Surgical Nabs FDA OK for Revision THA With Intellijoint HIP

  Intellijoint’s milestone supports Intellijoint Surgical’s mission of making intellijoint HIP accessible to every surgeon and every patient.

  November 1, 2017

   · 

  2 min read
• Policy

  MiMedx Agrees to Lawsuit Settlement With Halo Wound Solutions

  MiMedx announced today that the Company has agreed to a confidential settlement of the lawsuit the Company filed against BioResolutions LLC d/b/a Halo and one of the Halo executives.

  November 1, 2017

   · 

  4 min read
• Genetown

  Eleven Biotherapeutics Prices of $8M Underwritten Public Offering

  Eleven Biotherapeutics announced the pricing of an underwritten public offering of 5,525,000 shares of its common stock.

  November 1, 2017

   · 

  5 min read
• Genetown

  Pressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion Into China

  Pressure BioSciences announced that Professor Tiannan Guo’s laboratory at Westlake Institute for Advanced Study (“WIAS”) has been named the Company’s first Center of Excellence (“CoE”) in China.

  November 1, 2017

   · 

  6 min read
• Drug Development

  Novartis Presents Data at ASH for Patients With Serious Blood Disorders Like Lymphoma, Leukemia and Sickle Cell Disease

  The 59th American Society of Hematology Annual Meeting & Exposition will be held in Atlanta on December 9-12.

  November 1, 2017

   · 

  12 min read
• Drug Development

  Actinium Pharmaceuticals Announces Multiple Posters/Abstracts Accepted for 59th Annual American Society of Hematology Meeting Highlighting Company’s Drug Candidates and Technology Platform

  A poster presentation will highlight data from Actinium’s Phase 2 trial of Actimab-A in patients newly diagnosed with acute myeloid leukemia.

  November 1, 2017

   · 

  9 min read
• Pharm Country

  Fortress Biotech Announces Proposed Public Offering of Series A Preferred Stock

  All of the shares to be sold in the offering will be offered by Fortress.

  November 1, 2017

   · 

  4 min read
• Business

  Cascadian Therapeutics to Report Third Quarter 2017 Financial Results on November 8, 2017

  Management will host a conference call and live audio webcast to discuss the results and provide a general corporate update

  November 1, 2017

   · 

  1 min read
• Drug Development

  Inovio Pharmaceuticals Initiates Immuno-Oncology Clinical Study for Glioblastoma in Combination with Regeneron’s PD-1 Inhibitor

  Phase 1b/2a clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s T cell activator INO-5401 in brain cancer.

  November 1, 2017

   · 

  6 min read